Problems in the treatment of rheumatoid arthritis and prospects for the use of an IL-1 inhibitor (Anakinra). (Resolution of the Expert Council, May 19, 2022)
.
Saved in:
| Main Author: | article Editorial |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2022-11-01
|
| Series: | Научно-практическая ревматология |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/3231 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Resolution of the Council of Excperts (16th June, 2022): Therapy of gouty arthritis with an IL-1 inhibitor (anakinra)
by: E. L. Nasonov, et al.
Published: (2022-12-01) -
Resolution of the Scientific Council of Experts: “The place of netakimab, a new inhibitor of IL-17A, in the treatment of psoriatic arthritis
by: article Editorial
Published: (2020-09-01) -
RESOLUTION ON THE RESULTS OF THE EXPERT COUNCIL
by: article Editorial
Published: (2024-02-01) -
Resolution of the Expert Council of the Russian society of psychiatrists (of the meeting on May 17, 2017, Saint-Petersburg)
by: Editorial Article
Published: (2018-07-01) -
Resolution of the Independent Expert Council of The Union of Experts in the Field of Immunoprophylaxis
by: article Editorial
Published: (2023-08-01)